Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose

Prediction score of hypoglycemia after administered an intravenous regular insulin with glucose for hyperkalemia treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210225002

Enrollment

200

Registered

2021-02-25

Start date

2021-02-26

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalemia is one of important conditions that we should not underestimate it. Global prevalence of hyperkalemia is reported to be 5%. The current regimen of hyperkalemic patients is managed by 10 international units (IU) regular insulin with 25 grams glucose intravenously (IV) contributed to hypoglycemia. Hypoglycemia is a common complication of insulin treatment in hyperkalemic patients. clinical decision rule hyperkalemia hypoglycemia insulin

Interventions

Patients who diagnosed as hyperkalemia

Prevention

hyperkalemic patient

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who equal or more than 18 years old with diagnosed as hyperkalemia or serum potassium > 5.3 mmol/L

Exclusion criteria

Exclusion criteria: Patients with incomplete of important data, pregnant

Design outcomes

Primary

Measure	Time frame
hypoglycemia after insulin administration blood glucose	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactTheerapon Tangsuwanaruk

Department of Emergency Medicine, Faculty of Medicine, Chiang Mai University

theerapon.t@cmu.ac.th6653936722

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026